A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
Clinical trial NCT01308684 · COMPLETED
Trial details
- NCT number
- NCT01308684
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-02-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.